FI20012565A - Products for use in immunisuppressive therapy - Google Patents

Products for use in immunisuppressive therapy Download PDF

Info

Publication number
FI20012565A
FI20012565A FI20012565A FI20012565A FI20012565A FI 20012565 A FI20012565 A FI 20012565A FI 20012565 A FI20012565 A FI 20012565A FI 20012565 A FI20012565 A FI 20012565A FI 20012565 A FI20012565 A FI 20012565A
Authority
FI
Finland
Prior art keywords
immunisuppressive
therapy
products
immunisuppressive therapy
Prior art date
Application number
FI20012565A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20012565A0 (en
Inventor
Eero Mervaala
Original Assignee
Eero Mervaala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eero Mervaala filed Critical Eero Mervaala
Priority to FI20012565A priority Critical patent/FI20012565A/en
Publication of FI20012565A0 publication Critical patent/FI20012565A0/en
Priority to AU2002345121A priority patent/AU2002345121A1/en
Priority to PCT/FI2002/000542 priority patent/WO2003055480A1/en
Publication of FI20012565A publication Critical patent/FI20012565A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20012565A 2001-12-21 2001-12-21 Products for use in immunisuppressive therapy FI20012565A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20012565A FI20012565A (en) 2001-12-21 2001-12-21 Products for use in immunisuppressive therapy
AU2002345121A AU2002345121A1 (en) 2001-12-21 2002-06-19 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor
PCT/FI2002/000542 WO2003055480A1 (en) 2001-12-21 2002-06-19 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20012565A FI20012565A (en) 2001-12-21 2001-12-21 Products for use in immunisuppressive therapy

Publications (2)

Publication Number Publication Date
FI20012565A0 FI20012565A0 (en) 2001-12-21
FI20012565A true FI20012565A (en) 2003-06-22

Family

ID=8562570

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20012565A FI20012565A (en) 2001-12-21 2001-12-21 Products for use in immunisuppressive therapy

Country Status (3)

Country Link
AU (1) AU2002345121A1 (en)
FI (1) FI20012565A (en)
WO (1) WO2003055480A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439477C2 (en) * 1994-11-08 1999-10-21 Asta Medica Ag Use of R, S - (+/-) - alpha-lipoic acid, R - (+) - alpha-lipoic acid, S - (-) - alpha-lipoic acid in reduced or oxidized form or the metabolites and their salts, esters, amides for the treatment of diabetic microangiopathy
US5990153A (en) * 1997-05-05 1999-11-23 Wood; John G. Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
JP2004510694A (en) * 2000-05-08 2004-04-08 ヘインズ　デイビッド Immunosuppressive composition
DE10030378A1 (en) * 2000-06-21 2002-03-14 Audit Inst For Medical Service New pharmaceutical composition for topical application of water-insoluble and / or poorly water-soluble active ingredients
WO2001097832A1 (en) * 2000-06-21 2001-12-27 Audit Institute For Medical Services And Quality Assurance Gmbh Pharmaceutical preparations containing cyclosporines and neutral oils
WO2002017959A2 (en) * 2000-08-28 2002-03-07 Wisconsin Alumni Research Foundation Immunosuppression using piceatannol and a calcineurin inhibitor

Also Published As

Publication number Publication date
WO2003055480A1 (en) 2003-07-10
AU2002345121A1 (en) 2003-07-15
FI20012565A0 (en) 2001-12-21

Similar Documents

Publication Publication Date Title
EE04528B1 (en) Aralam laminates for use in therapy for spirofurop ridins
DK1406633T3 (en) Improved drug delivery in transdermal systems
IS2986B (en) New synthetic multilayer agent for use in human therapy
AR028622A1 (en) USEFUL TROPANO DERIVATIVES IN THERAPY
NO20054681D0 (en) Pharmaceutical products
DE60203429D1 (en) Absorbent disposable article
HK1069349A1 (en) Powered sterile solution device
BR0209135B1 (en) disposable dressing article.
DE60212066D1 (en) SUPPLY SYRINGE
EE200300311A (en) Phthalazinone-piperidine derivatives, their use and medicine
NO20020531D0 (en) Beta-carbolin drug products
NO20050689L (en) Therapeutic use
DE50209245D1 (en) NEUROPROTEKTIVES MEDICAMENT
ATE322161T1 (en) SUBSTANCE DELIVERY DEVICE
ATE374011T1 (en) SKIN TREATMENT PRODUCTS
DE50005409D1 (en) STOP TREATMENT DEVICE
DE60221068D1 (en) Device for deep-acting skin therapy
FI20012565A0 (en) Products for use in immunisuppressive therapy
AU2003215767A8 (en) Devices for use in medicine
EE200300466A (en) Use of pyridoindolone derivatives in the preparation of medicaments
EE200300025A (en) CRF2 ligands for use in combination therapy
NO20044090L (en) Substituted 3-Phenyl-5-alkoxy-1,3,4-oxadiazole-24 neR, its preparation and use in medicaments
SE0101141D0 (en) Device for medical use
NO20011711D0 (en) Chair
DK1361264T3 (en) Products containing beta-glucans

Legal Events

Date Code Title Description
MA Patent expired